Krystal Biotech (NASDAQ: KRYS) STOCK RECOMMENDATION
Idea | BUY |
Buy Range | 185 – 188 |
Target | 200 – 203 |
StopLoss* | below 180 |
Duration | 12-14 Trading Days |
Potential Returns | 6% – 8% |
Idea | Buy Range | Target | StopLoss* | Duration | Potential Returns |
BUY | 185 – 188 | 200 – 203 | below 180 | 12-14 Trading Days | 6% – 8% |
* Once the first target hit, reset the StopLoss at your buying price.
Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview. Be assured such records are permanent and irreversible.
Krystal Biotech (NASDAQ: KRYS) STOCK OVERVIEW
Krystal Biotech, Inc. is a biotechnology company that focuses on discovering, developing, and commercializing genetic medicines for rare diseases in the United States. The company’s current focus is on commercializing VYJUVEK for the treatment of dystrophic epidermolysis bullosa, as well as developing several other genetic medicines for various rare diseases. Founded in 2016, Krystal Biotech, Inc. is based in Pittsburgh, Pennsylvania.
Stock Data | |
NASDAQ Symbol | KRYS |
Sectoral Index | Health Care |
52 Weeks High | 192.49 |
52 Weeks Low | 93.95 |
Krystal Biotech (NASDAQ: KRYS) - RELATIVE STRENGTH

Relative Performance - Last 1 Year
Krystal Biotech — NASDAQ —
Krystal Biotech (NASDAQ: KRYS) - DAILY TECHNICAL ANALYSIS

- 130 level acted as a strong resistance for the price initially.
- With a bullish candle, the price broke above this level and reached a new high near 190.
- However, the price couldn’t hold above this level and corrected.
- Following a brief consolidation, the price formed an Ascending Triangle pattern and broke out again.
- If the price remains above 185, there is potential for further upward movement.
Krystal Biotech (NASDAQ: KRYS) - RSI

- Current RSI of this stock is 68.18, which indicates the strength of buyers.
Krystal Biotech (NASDAQ: KRYS) - RSI

- Current RSI of this stock is 68.18, which indicates the strength of buyers.
Krystal Biotech (NASDAQ: KRYS) - MACD

- MACD line has crossed the signal line from the below, generates bullish signal.
Krystal Biotech (NASDAQ: KRYS) - ADX & DI

- Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
CONCLUSION - Krystal Biotech (NASDAQ: KRYS) STOCK PRICE FORECAST
Based on our stock trading advice in USA, Krystal Biotech stock price target will be USD 200 – USD 203 in the next 12-14 trading sessions.